Example: Heart Attack

Clinical Trials Sponsored by STAND, Inc

Total 9 results

    • NCT00260780
      Completed
      An STD Prevention Intervention for Men Newly Released From Jail
      Conditions: Sexually Transmitted Diseases; Risk Behavior
    • NCT04434040
      Suspended
      Ipatasertib + Atezolizumab to Prevent Recurrence in TNBC
      Conditions: Breast Cancer; Triple Negative Breast Cancer; Residual Cancer; Circulating Tumor DNA
    • NCT03566485
      Active, not recruiting
      Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer
      Conditions: Stage III Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer; Estrogen Receptor-positive; HER2/Neu Negative
    • NCT04524195
      Not yet recruiting
      PET Imaging With [18F]F-AraG in Advanced Non-small Cell Lung Cancer (NSCLC)
      Conditions: Non-small Cell Lung Cancer (NSCLC)
    • NCT02719977
      Active, not recruiting
      A Phase I Study of CX5461
      Conditions: Cancer
    • NCT01088815
      Completed
      Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas
      Conditions: Metastatic Pancreatic Cancer
    • NCT03554083
      Recruiting
      Neoadjuvant Combination Targeted and Immunotherapy for Patients With High-Risk Stage III Melanoma
      Conditions: Clinical Stage III Cutaneous Melanoma AJCC v8; Pathologic Stage III Cutaneous Melanoma AJCC v8; Pathologic Stage IIIA Cutaneous Melanoma AJCC v8; Pathologic Stage IIIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8; Pathologic Stage IIID Cutaneous Melanoma AJCC v8
    • NCT04134884
      Recruiting
      Study of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast Cancer
      Conditions: Metastatic Breast Cancer; Triple Negative Breast Cancer; Hormone Receptor Positive Tumor
    • NCT03215810
      Active, not recruiting
      Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer
      Conditions: Non-Small Cell Lung Cancer; Metastatic Non-small Cell Lung Cancer; Squamous Cell Carcinoma; Advanced NSCLC; Adenosquamous Carcinoma; Adenocarcinomas
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations